Business Categories Reports Podcasts Events Webinars
Contact My Account About

Crown Laboratories Expands Aesthetics Portfolio

May 27, 2022
May 27, 2022
Nati Melnychuk via Unsplash

Crown Laboratories, a leading, fully integrated global skincare company, has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aesthetics-focused assets.

WHO: Eclipse was established in January 1993 as a specialty surgical supply company. It quickly became a successful privately held medical device company and one of the pioneers in the aesthetic market, launching several energy-based devices globally. For more than 28 years, Eclipse has been an innovative leader in advancing medical technologies to bring medical supplies to practices in the US and around the globe. Based in Dallas, Eclipse manufactures and distributes high-efficacy, affordable products to physicians that exceed patient expectations and put immediate profit into their partners' practices.

Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium, and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. Crown has been listed on the Inc. 5000 Fastest-Growing Privately Held Companies List for eight years and has expanded its distribution to over 38 countries.

WHY: The acquisition of Eclipse Medcorp expands Crown's aesthetics product portfolio and enhances Crown's overall value proposition as a global leader in science-based aesthetic skincare solutions.

IN THEIR OWN WORDS: "We pride ourselves on being at the forefront of today's aesthetics market by developing and delivering best-in-class medical technologies and products that are exceptionally safe and effective," said Jeff Bedard, President and CEO of Crown. "This strategic acquisition furthers Crown's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Eclipse's excellent products will broaden our product line and customer base, domestically and internationally."

"We are thrilled to have completed this transaction with Crown," added Paul O'Brien, CEO of Eclipse. "The combination of Eclipse's innovative product offerings with Crown's leadership position in the aesthetics market will undoubtedly expand the reach and optimize the range of services health care professionals can provide to their patients."


  • Crown Laboratories acquires Eclipse Medcorp's global, aesthetics-focused assets. 
  • Crown will integrate the Eclipse products into the Aesthetics business unit of Crown to complement its award-winning SkinPen Precision and other brands.

2 Article(s) Remaining

Subscribe today for full access